enow.com Web Search

  1. Ads

    related to: takotsubo treatment guidelines for diabetes

Search results

  1. Results from the WOW.Com Content Network
  2. Takotsubo cardiomyopathy - Wikipedia

    en.wikipedia.org/wiki/Takotsubo_cardiomyopathy

    The treatment of takotsubo cardiomyopathy is generally supportive in nature, for it is considered a transient disorder. [45] Treatment is dependent on whether patients experience heart failure or acute hypotension and shock. In many individuals, left ventricular function normalizes within two months.

  3. Dipeptidyl peptidase-4 inhibitor - Wikipedia

    en.wikipedia.org/wiki/Dipeptidyl_peptidase-4...

    A 2020 Cochrane systematic review did not find enough evidence of reduction of all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes. [25]

  4. Linagliptin - Wikipedia

    en.wikipedia.org/wiki/Linagliptin

    Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat type 2 diabetes (but not type 1) in conjunction with exercise and diet. [8] [9] It is generally less preferred than metformin and sulfonylureas as an initial treatment. [8] [10] It is taken by mouth. [8] Common side effects include inflammation of the ...

  5. Talk:Takotsubo cardiomyopathy - Wikipedia

    en.wikipedia.org/wiki/Talk:Takotsubo_cardiomyopathy

    Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Takotsubo cardiomyopathy. PubMed provides review articles from the past five years (limit to free review articles)

  6. Vildagliptin - Wikipedia

    en.wikipedia.org/wiki/Vildagliptin

    Vildagliptin, sold under the brand name Galvus and others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

  7. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]

  1. Ads

    related to: takotsubo treatment guidelines for diabetes